Marty Glick

Marty Glick is in his eighth season with the Golden State Warriors, his sixth as special advisor to ownership. In this capacity, Glick is primarily responsible for advising ownership on major strategic issues including the financing of Chase Center, the team’s state-of-the-art sports and entertainment center slated to open in the fall of 2019 in San Francisco and other major strategic initiatives. He is also a board member for the Warriors Community Foundation.

Prior to assuming his current role in the summer of 2013, Glick served two seasons as chief financial officer for the Warriors, overseeing all financial strategy, planning and accounting for the organization. He is also a minority owner.

A highly-regarded former biotech executive whose affiliations have a history of innovative success, Glick has accumulated a wealth of experience as a prominent financial figure for several large biotech businesses during his career. He spent more than a decade (1987-1997) at Genentech of South San Francisco, where he most recently served as vice president of finance. He also served as executive vice president and chief financial officer of Theravance, a Bay Area-based drug discovery company, for seven years (1998-2005) and was a co-founder and board member of Eyetech Pharmaceuticals.

Additionally, Glick was co-founder and chairman of the board of PEAK Surgical – an innovative private medical device company – and his résumé also includes a seven-plus year stint as the chair of the Biotech Tax and Finance Committee. A native of Chicago, Glick earned his MBA in Finance at Kellogg School of Management at Northwestern University, his Bachelor of Science in Business Administration (BSBA) in Accounting at Creighton University and is also a CPA and Chartered Accountant (Ontario, Canada).